Data from Cempra’s CEM-101 Phase 2 trial on N. gonorrhoeae infections to be presented at ECCMID – News-Medical.Net

The drug candidate has shown comparable efficacy and favorable safety and tolerability in a Phase 2 trial in community-acquired bacterial pneumonia patients when tested against levofloxacin. The investigators compared the activity of …

Leave a Reply

Your email address will not be published.